NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

Name

Capella University

NURS-FPX 6030 MSN Practicum and Capstone

Prof. Name

Date

Problem Statement

The management of sepsis, a condition that can be fatal, in adult patients admitted to intensive care units depends significantly on the timing of antibiotic administration. The question arises: In adult patients admitted to intensive care units (Population), is the early usage of broad-spectrum antibiotics (Intervention) compared to delayed usage (Comparison) interconnected with a lower mortality rate (Outcome) within the first 72 hours of sepsis diagnosis (Time)? Understanding this temporal relationship is essential for refining clinical protocols, potentially leading to more effective interventions and improved outcomes for patients grappling with sepsis in intensive care settings.

Needs Assessment

The project seeks to lead organizational change by addressing a critical need in the healthcare setting, specifically focused on adult patients admitted to intensive care units diagnosed with sepsis. Compared to delayed usage, the intervention centers around implementing an early usage of broad-spectrum antibiotics to lower mortality rates within the first 72 hours of sepsis diagnosis. This intervention aligns with health promotion and quality improvement objectives, aiming to enhance the overall experience of care, improve population health outcomes, and optimize the work life of healthcare professionals. The identified need is urgent as sepsis is a time-sensitive condition, and evidence strongly supports the notion that early administration of broad-spectrum antibiotics is interconnected with a lower mortality rate.

Delayed treatment can significantly worsen patient outcomes and increase mortality rates, making timely intervention imperative. The urgency is underscored by studies demonstrating that a prompt response within the crucial 72-hour window is associated with improved survival rates and reduced healthcare costs (Martínez et al., 2020). By implementing this intervention, the project addresses a vital health promotion and quality improvement need by emphasizing the importance of timely and effective sepsis management. The assumptions underlying this analysis include the belief that proactive measures in sepsis care, like early antibiotic intervention, will positively impact patient outcomes and decrease overall healthcare costs. Furthermore, it assumes that organizational changes supporting timely interventions will lead to a more efficient, cost-effective, and patient-centered healthcare system by contributing to improved experiences of care, population health, and the work life of healthcare professionals (Rhee et al., 2020).

Population and Settings

The project targets adult patients admitted to intensive care units (ICUs) diagnosed with sepsis as the specific population, given the urgency and severity of sepsis cases. The ICU setting is chosen for its specialized resources, skilled healthcare professionals, and advanced monitoring capabilities by aligning with the critical requirements of sepsis management. The identified need within this setting focuses on improving patient outcomes through the early use of broad-spectrum antibiotics within the first 72 hours of sepsis diagnosis. Effectively addressing this need is crucial for positively impacting mortality rates and aligns with health promotion and quality improvement objectives. Challenges in this initiative may include navigating the intricate nature of ICU care, overcoming potential resistance to protocol changes, and ensuring seamless coordination among healthcare teams. Despite these challenges, the specialized environment of ICUs provides an opportunity for focused and intensive implementation of the quality improvement method (Al-Sunaidar et al., 2020).

The importance of this project lies in its potential to enhance patient outcomes in a time-sensitive condition, supported by evidence linking early antibiotic intervention to lower mortality rates. The initiative aligns with broader goals of improving the patient experience, population health outcomes, and optimizing the work life of healthcare professionals within the critical ICU setting. Assumptions guiding this initiative include the belief that proactive measures, like early antibiotic intervention, will positively impact patient outcomes and decrease healthcare costs. The project aligns with the overarching goal of leading organizational change to enhance the quality of care while being mindful of cost-effectiveness and the professional well-being of healthcare practitioners within the targeted ICU population and setting (Gauer et al., 2020).

Intervention Overview

A multifaceted intervention strategy is proposed to improve sepsis management in adult ICU patients. Firstly, evidence-based clinical protocols will guide healthcare professionals in early broad-spectrum antibiotic administration within the critical first 72 hours of sepsis diagnosis. Tailored to the urgent needs of the target population, these protocols aim to streamline decision-making and ensure timely interventions, directly addressing the identified need for prompt sepsis management. Secondly, educational initiatives will enhance healthcare professionals’ knowledge and awareness of the importance of early antibiotic intervention in sepsis cases. Designed to fit the ICU setting, these programs consider the challenges of ICU care, fostering a culture of continuous learning and awareness. This intervention promotes a proactive approach to sepsis management among healthcare professionals (Sendak et al., 2020). While both interventions effectively address the identified need, potential challenges such as changing established protocols and the need for ongoing education will be systematically addressed through stakeholder engagement, continuous training, and quality improvement processes. The combined strategy aims to comprehensively address the identified need by integrating clinical protocols and educational initiatives tailored to the unique characteristics of the target population and setting (Sendak et al., 2020).

Comparison of Approaches

An alternative approach to improving sepsis management in adult ICU patients involves establishing a dedicated rapid response team comprising various healthcare professionals, including physicians, nurses, pharmacists, and respiratory therapists. This interdisciplinary team collaborates to ensure swift and coordinated responses to sepsis cases within critical hours by fostering a complete and interprofessional approach to patient care. Unlike the initial intervention, this alternative promotes interprofessional care by leveraging the collective expertise of diverse healthcare professionals, enabling a comprehensive strategy that addresses timely antibiotic administration and critical aspects of sepsis management, such as continuous monitoring and immediate adjustments to the care plan (Uffen et al., 2021).

This alternative aligns well with the adult ICU population’s specialized and complex medical needs, addressing unique challenges associated with ICU care through team members’ diverse skill sets and expertise. In the ICU setting, the rapid response team seamlessly aligns with the time-sensitive nature of critical care, facilitating prompt mobilization and responses to sepsis cases within the crucial 72-hour window. This alternative proves favorable in addressing the identified need for prompt and effective sepsis management. The collaborative efforts of the rapid response team offer a holistic and timely approach, potentially enhancing patient outcomes and reducing sepsis-related mortality rates. Acknowledging potential challenges, such as efficient coordination and consistent availability of diverse professionals, emphasizes the importance of proactive management through effective communication, ongoing training programs, and continuous quality improvement processes for successful implementation (Wulff et al., 2019).

Initial Outcome Draft

The defined outcome is a substantial reduction in sepsis-related mortality within the first 72 hours through early broad-spectrum antibiotic administration in adult ICU patients. Aligned with the intervention’s purpose of health promotion, quality improvement, and patient safety, this outcome reflects a targeted and measurable goal. Focusing on lowering mortality rates underscores the urgency of timely intervention, emphasizing the potential life-saving impact of early antibiotics. This outcome serves an apparent objective by establishing a framework for enhancing the quality and safety of care for septic patients in ICUs. It highlights the pivotal role of swift and effective interventions in mitigating the risk of fatal outcomes, illustrating the project’s intent to make a tangible impact.

To assess achievement, criteria include a statistically significant decrease in mortality rates, a comparative analysis of outcomes between early and delayed antibiotic administration, and adherence to established protocols within the 72-hour window. These criteria provide a robust evaluation framework by ensuring that the intervention’s success is objectively measured and contributes to health promotion, quality improvement, and preventing adverse outcomes. The outcome signifies the purpose and intended accomplishments of the intervention. It establishes a meaningful benchmark for evaluating success in enhancing the overall care experience for septic patients in intensive care settings.

Time Estimate

The development of the intervention focusing on the early usage of broad-spectrum antibiotics in adult ICU patients to lower sepsis-related mortality would span approximately 12-18 months. This time frame allows for a comprehensive review of existing literature by consultation with experts and the design of evidence-based protocols. While realistic, potential challenges such as navigating regulatory approvals, coordinating multidisciplinary input, and addressing unforeseen obstacles in protocol development may impact this timeframe. The implementation phase, involving the integration of the intervention into ICU practices, is estimated to require an additional 18-24 months. This period includes training healthcare staff, modifying existing workflows, and establishing a robust monitoring and feedback system. While deemed realistic, challenges may arise from resistance to change among healthcare professionals, logistical issues in implementing new protocols, and the need for ongoing adjustments based on real-world feedback. Identifying and proactively addressing these challenges will be crucial to ensuring the successful development and implementation of the intervention within the proposed time frames.

Literature Review

Investigating the early usage of broad-spectrum antibiotics in adult patients admitted to intensive care units (ICUs) and its potential correlation with lower mortality rates within the initial 72 hours of sepsis diagnosis involves an in-depth analysis of current evidence. Evaluating this evidence validates the identified need and explores its appropriateness within the target population and setting by considering relevance, currency, sufficiency, and trustworthiness. The Surviving Sepsis Campaign Guidelines, a cornerstone in sepsis management, consistently undergo updates based on the latest meta-analyses and expert consensus. The evidence within these guidelines robustly underscores the significance of early antibiotic intervention in adult ICU patients diagnosed with sepsis (Suh et al., 2023).

In another study, the guidelines validated the identified need and established its relevance within a comprehensive approach to improving patient outcomes in diverse healthcare settings (Schorr et al., 2022). The evidence supporting the appropriateness of early antibiotic intervention within the target population. The evidence validates the identified need and showcases its currency and relevance in contemporary ICU settings by demonstrating a clear association between early, goal-directed therapy (including antibiotic usage) and reduced mortality rates. The study’s impact has led to the worldwide integration of early interventions into sepsis management protocols (Rothrock et al., 2020).

A study by Kollef et al. (2021) further contributes to the comprehensive validation of the identified need. By highlighting the critical role of timely initiation of effective antimicrobial therapy in improving survival rates among adult ICU patients with septic shock, this evidence emphasizes the relevance and sufficiency of early antibiotic administration within the specified timeframe. The study of Al-Kader et al. (2022) findings has influenced sepsis treatment guidelines, emphasizing the importance of prompt antibiotic intervention. The study provides valuable insights of sepsis, especially within the unique setting of ICUs. The evidence robustly validates the appropriateness of addressing the identified need in ICU settings by emphasizing the crucial role of timely interventions.

NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

The observed impact of time to treatment on sepsis mortality rates underscores the relevance and trustworthiness of this evidence, further reinforcing the identified need for early antibiotic administration (Im et al., 2022). The study explores the impact of rapid antibiotic administration on patient outcomes in ICUs. By delving into the time-sensitive nature of antibiotic delivery, the evidence provides insights into the practical implications of early intervention, further substantiating the identified need. The study’s findings contribute to the ongoing discourse on optimizing antibiotic administration in critical care settings (Asner et al., 2021).

Focusing on patient-centered outcomes, this study evaluates the impact of early sepsis interventions, including antibiotic administration, on patients’ overall experiences and satisfaction. By considering the holistic effects of early interventions, the evidence enhances our understanding of the identified need’s appropriateness in promoting patient-centered care and improving the quality of the overall healthcare experience in ICUs (Artigas et al.,2022). Focusing on antibiotic timing in the setting of emerging resistant strains, this evidence addresses a critical aspect of appropriateness within the evolving landscape of sepsis management. The study’s findings contribute valuable insights into adapting early antibiotic intervention strategies to mitigate the challenges of emerging antibiotic resistance, thereby enhancing the overall relevance and currency of the identified need (Arulkumaran et al., 2020). The extensive evidence analysis solidifies the need for early use of broad-spectrum antibiotics in adult ICU patients within the first 72 hours of sepsis diagnosis. This analysis validates the need and elucidates its appropriateness within the target population and setting, considering multiple dimensions of evidence quality, relevance, and currency ( Busch & Kadri, 2020).

Evaluation and Synthesis of Relevant Health Policy

The Centers for Medicare & Medicaid Services (CMS) Sepsis Management Guidelines are pivotal in shaping healthcare practices for diagnosing, treating, and reporting sepsis cases. These guidelines emphasize the critical aspects of early recognition, timely interventions, and adherence to evidence-based practices in sepsis management. The policy’s impact on addressing the identified need is substantial, given that CMS guidelines hold sway over reimbursement structures and quality ratings for healthcare facilities. Compliance with these guidelines is necessary for regulatory adherence and financial viability (Kempker et al., 2019). Incorporating evidence-based clinical protocols aligned with CMS recommendations for sepsis care is a crucial consideration for the project. Continuous monitoring and documentation of sepsis care practices will be essential to meet reporting requirements mandated by CMS. However, challenges emerge in balancing strict adherence to guidelines and the need for flexible intervention approaches. Modifications may become necessary to strike a balance that ensures policy compliance while addressing the unique needs of the target population and setting (Pakyz et al., 2020).

The National Institute for Health and Care Excellence (NICE) provides evidence-based guidelines that significantly influence healthcare practices, including those related to sepsis. The NICE Sepsis Guidelines offer comprehensive recommendations for healthcare professionals recognizing, diagnosing, and managing sepsis, emphasizing early intervention and the prompt administration of antibiotics. This policy is particularly relevant to the identified need as it contributes additional perspectives and standards to guide effective sepsis care (Goel et al., 2019). Incorporating NICE guidelines into the project is imperative for enhancing the evidence-based approach to sepsis management. Aligning the project interventions with NICE recommendations will enhance patient outcomes and contribute to quality improvement goals. Staying informed about updates or revisions to NICE guidelines is crucial to ensuring the project remains current and aligned with evolving standards. Collaboration with healthcare professionals is essential to implement interventions that align with CMS and NICE guidelines, considering any variations or intersections between the two recommendations (Hershkovich–Shporen et al., 2021).

Conclusion

In conclusion, this assessment highlights the urgency of addressing sepsis in adult ICU patients through early broad-spectrum antibiotic intervention. The proposed strategy, aligning with health promotion objectives, seeks to reduce mortality rates within 72 hours. The alternative rapid response team approach offers an interdisciplinary solution, addressing challenges in the complex ICU setting. With a clear outcome of lowering sepsis-related mortality, this comprehensive assessment provides a robust foundation for a timely, evidence-based intervention, promising significant improvements in patient care within intensive care settings.

References

Al-Kader, D. A., Anwar, S., Hussaini, H., Jones Amaowei, E. E., Rasuli, S. F., Hussain, N., Kaddo, S., & Memon, A. (2022). Systematic review on the effects of prompt antibiotic treatment on survival in septic shock and sepsis patients in different hospital settings. Cureushttps://doi.org/10.7759/cureus.32405 

Al-Sunaidar, K. A., Prof. Abd Aziz, N., & Prof. Hassan, Y. (2020). Appropriateness of empirical antibiotics: Risk factors of adult patients with sepsis in the ICU. International Journal of Clinical Pharmacy42(2), 527–538. https://doi.org/10.1007/s11096-020-01005-4 

Artigas, R. M, Ferrando, C., Martino, F., Delbove, A., Ferreyro, B. L., Darreau, C., Jacquier, S., Brochard, L., & Lerolle, N. (2022). Early intubation and patient-centered outcomes in septic shock: A secondary analysis of a prospective multicenter study. Critical Care26(163). https://doi.org/10.1186/s13054-022-04029-6 

Arulkumaran, N., Khpal, M., Tam, K., Baheerathan, A., Corredor, C., & Singer, M. (2020). Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically ill septic patients. Critical Care Medicine48(5), 757–764. https://doi.org/10.1097/ccm.0000000000004267 

Asner, S. A., Desgranges, F., Schrijver, I. T., & Calandra, T. (2021). Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock. Journal of Infection, 82(5), 125–134. https://doi.org/10.1016/j.jinf.2021.03.003 

Busch, L. M., & Kadri, S. S. (2020). Antimicrobial treatment duration in sepsis and serious infections. The Journal of Infectious Diseases222(2), S142–S155. https://doi.org/10.1093/infdis/jiaa247 

Hershkovich–Shporen, C., Guri, A., Gluskina, T., & Flidel‐Rimon, O. (2021). Centers for disease control and prevention guidelines identified more neonates at risk of early‐onset sepsis than the Kaiser‐Permanente calculator. Acta Paediatrica. https://doi.org/10.1111/apa.16232 

Gauer, R., Forbes, D., & Boyer, N. (2020). Sepsis: Diagnosis and management. American Family Physician101(7), 409–418. https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html?utm_medium=email&utm_source=transaction 

NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

Goel, N., Shrestha, S., Smith, R., Mehta, A., Ketty, M., Muxworthy, H., Abelian, A., Kirupaalar, V., Saeed, S., Jain, S., Asokkumar, A., Natti, M., Barnard, I., Pitchaikani, P. K., & Banerjee, S. (2019). Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population. Archives of Disease in Childhood – Fetal and Neonatal Edition105(2), 118–122. https://doi.org/10.1136/archdischild-2018-316777 

Im, Y., Kang, D., Ko, R.-E., Lee, Y. J., Lim, S. Y., Park, S., Na, S. J., Chung, C. R., Park, M. H., Oh, D. K., Lim, C.-M., Suh, G. Y., Lim, C.-M., Hong, S.-B., Oh, D. K., Suh, G. Y., Jeon, K., Ko, R.-E., Cho, Y.-J., & Lee, Y. J. (2022). Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: A prospective nationwide multicenter cohort study. Critical Care26(1). https://doi.org/10.1186/s13054-021-03883-0 

Kempker, J. A., Kramer, M. R., Waller, L. A., Wang, H. E., & Martin, G. S. (2019). State-level hospital compliance with and performance in the centers for medicaid & medicare services’ early management severe sepsis and septic shock bundle. Critical Care, 23(1). https://doi.org/10.1186/s13054-019-2382-0 

Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021). Timing of antibiotic therapy in the ICU. Critical Care25(1). https://doi.org/10.1186/s13054-021-03787-z 

Martínez, M. L., Plata-Menchaca, E. P., Ruiz-Rodríguez, J. C., & Ferrer, R. (2020). An approach to antibiotic treatment in patients with sepsis. Journal of Thoracic Disease12(3), 1007–1021. https://doi.org/10.21037/jtd.2020.01.47 

Pakyz, A. L., Orndahl, C. M., Johns, A., Harless, D. W., Morgan, D. J., Bearman, G., Hohmann, S. F., & Stevens, M. P. (2020). Impact of the centers for medicare and medicaid services sepsis core measure on antibiotic use. Clinical Infectious Diseases72(4), 556–565. https://doi.org/10.1093/cid/ciaa456 

Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., & Klompas, M. (2020). Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Network Open3(4), e202899. https://doi.org/10.1001/jamanetworkopen.2020.2899 

NURS FPX 6030 Assessment 2 Problem Statement (PICOT)

Rothrock, S. G., Cassidy, D. D., Barneck, M., Schinkel, M., Guetschow, B., Myburgh, C., Nguyen, L., Earwood, R., Nanayakkara, P. W. B., Nannan Panday, R. S., & Briscoe, J. G. (2020). Outcome of immediate versus early antibiotics in severe sepsis and septic shock: A systematic review and meta-analysis. Annals of Emergency Medicine76(4). https://doi.org/10.1016/j.annemergmed.2020.04.042 

Sendak, M. P., Ratliff, W., Sarro, D., Alderton, E., Futoma, J., Gao, M., Nichols, M., Revoir, M., Yashar, F., Miller, C., Kester, K., Sandhu, S., Corey, K., Brajer, N., Tan, C., Lin, A., Brown, T., Engelbosch, S., Anstrom, K., & Elish, M. C. (2020). Real-world integration of a sepsis deep learning technology into routine clinical care: Implementation study. JMIR Medical Informatics, 8(7), e15182. https://doi.org/10.2196/15182 

Schorr, C. A., Seckel, M. A., Papathanassoglou, E., & Kleinpell, R. (2022). Nursing implications of the updated 2021 surviving sepsis campaign guidelines. American Journal of Critical Care31(4), 329–336. https://doi.org/10.4037/ajcc2022324 

Suh, G. J., Shin, T. G., Kwon, W. Y., Kim, K., Jo, Y. H., Choi, S. H., Sung Phil Chung, & Kim, Y.-J. (2023). Hemodynamic management of septic shock: Beyond of the SSC guidelines. Clinical and Experimental Emergency Medicinehttps://doi.org/10.15441/ceem.23.065 

Uffen, J. W., Oosterheert, J. J., Schweitzer, V. A., Thursky, K., Kaasjager, H. A. H., & Ekkelenkamp, M. B. (2020). Interventions for rapid recognition and treatment of sepsis in the emergency department: A narrative review. Clinical Microbiology and Infection27(2). https://doi.org/10.1016/j.cmi.2020.02.022 

Wulff, A., Montag, S., Marschollek, M., & Jack, T. (2019). Clinical decision-support systems for detection of systemic inflammatory response syndrome, sepsis, and septic shock in critically ill patients: A systematic review. Methods of Information in Medicine58(S 02), e43–e57. https://doi.org/10.1055/s-0039-1695717